Parkinsonian Disorders (diet therapy) < Parkinsonian Disorders (drug therapy) < Parkinsonian Disorders (economics)

Facettes :

List of bibliographic references indexed by Parkinsonian Disorders (drug therapy)

Number of relevant bibliographic references: 99.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000702 (2013)	Patrícia Pita Lobo ; Miguel Coelho ; Tiago A. Mestre ; Mário M. Rosa ; Joaquim J. Ferreira	Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism.
000767 (2013)	Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta	Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
000787 (2013)	Karen L. Eskow Jaunarajs [États-Unis] ; David G. Standaert ; Tacey X. Viegas ; Michael D. Bentley ; Zhihao Fang ; Bekir Dizman ; Kunsang Yoon ; Rebecca Weimer ; Paula Ravenscroft ; Tom H. Johnston ; Michael P. Hill ; Jonathan M. Brotchie ; Randall W. Moreadith	Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit.
000935 (2013)	Mun Kyung Sunwoo ; Kyung Min Kim ; Jin Yong Hong ; Young H. Sohn ; Phil Hyu Lee	Levodopa-induced dyskinesia in a patient who has normal presynaptic dopaminergic neurons.
000A51 (2013)	Susan Fox [Canada]	Commentary.
000D81 (2012)	Marianna Amboni [Italie] ; Paolo Barone ; Luigi Iuppariello ; Ilaria Lista ; Riccardo Tranfaglia ; Alfonso Fasano ; Marina Picillo ; Carmine Vitale ; Gabriella Santangelo ; Valeria Agosti ; Alessandro Iavarone ; Giuseppe Sorrentino	Gait patterns in Parkinsonian patients with or without mild cognitive impairment.
000E15 (2012)	Anthony C. Vernon ; Michel Modo	Do levodopa treatments modify the morphology of the parkinsonian brain?
000E91 (2012)	Paul B. Tawadros [Australie] ; Dennis Cordato ; Ian Cathers ; John A. Burne	An electromyographic study of parkinsonian swallowing and its response to levodopa.
000F29 (2012)	Maja Kojovic [Royaume-Uni] ; Una-Marie Sheerin [Royaume-Uni] ; Ignacio Rubio-Agusti [Royaume-Uni] ; Anirban Saha [Royaume-Uni] ; Jose Bras [Royaume-Uni] ; Vaneesha Gibbons [Royaume-Uni] ; Rodger Palmer [Royaume-Uni] ; Henry Houlden [Royaume-Uni] ; John Hardy [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]	Young-Onset Parkinsonism due to Homozygous Duplication of α-Synuclein in a Consanguineous Family
001309 (2011)	James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada]	The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease
001579 (2011)	Elisa Garbayo [Espagne] ; Eduardo Ansorena [Espagne] ; Jose Luis Lanciego [Espagne] ; María Jose Blanco-Prieto [Espagne] ; María S. Aymerich [Espagne]	Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease
001588 (2011)	Mathias Toft [Norvège] ; Espen Dietrichs [Norvège]	Levodopa‐responsive parkinsonism in probable extrapontine myelinolysis of the mesencephalon
001720 (2011)	Helen Ling [Royaume-Uni] ; Mark Braschinsky [Estonie] ; Pille Taba [Estonie] ; Siiri-Merike Lüüs [Estonie] ; Karen Doherty [Royaume-Uni] ; Anna Hotter [Autriche] ; Werner Poewe [Autriche] ; Andrew Lees (neurologue) [Royaume-Uni]	Decades of delayed diagnosis in 4 levodopa‐responsive young‐onset monogenetic parkinsonism patients
001944 (2010)	Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada]	The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates
001983 (2010)	Matthis Synofzik [Allemagne] ; Friedrich Asmus [Allemagne] ; Matthias Reimold [Allemagne] ; Ludger Schöls [Allemagne] ; Daniela Berg [Allemagne]	Sustained dopaminergic response of parkinsonism and depression in POLG‐associated parkinsonism
001A93 (2010)	Martin Köllensperger [Autriche] ; Felix Geser [Autriche] ; Jean-Pierre Ndayisaba [Autriche] ; Sylvia Boesch [Autriche] ; Klaus Seppi [Autriche] ; Karen Ostergaard [Danemark] ; Erik Dupont [Danemark] ; A. Cardozo [Espagne] ; Eduardo Tolosa [Espagne] ; Michael Abele [Allemagne] ; Thomas Klockgether [Allemagne] ; Farid Yekhlef [France] ; Francois Tison [France] ; Christine Daniels [Allemagne] ; Günther Deuschl [Allemagne] ; Miguel Coelho [Portugal] ; Cristina Sampaio [Portugal] ; Maria Bozi [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Anette Schrag [Royaume-Uni] ; Chris J. Mathias [Royaume-Uni] ; Clare Fowler [Royaume-Uni] ; Christer F. Nilsson [Suède] ; H Kan Widner [Suède] ; Nicole Schimke [Allemagne] ; Wolfgang Oertel [Allemagne] ; Francesca Del Sorbo [Italie] ; Alberto Albanese [Italie] ; Maria Teresa Pellecchia [Italie] ; Paolo Barone [Italie] ; Ruth Djaldetti [Israël] ; Carlo Colosimo [Italie] ; Giuseppe Meco [Italie] ; Antonio Gonzalez-Mandly [Espagne] ; Jose Berciano [Espagne] ; Tanya Gurevich [Israël] ; Nir Giladi [Israël] ; Monique Galitzky [France] ; Olivier Rascol [France] ; Christoph Kamm [Allemagne] ; Thomas Gasser [Allemagne] ; Uwe Siebert [Autriche, États-Unis] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]	Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry
001B07 (2010)	Victoria Newsway [Royaume-Uni] ; Mark Fish [Royaume-Uni] ; Jonathan D. Rohrer [Royaume-Uni] ; Elisa Majounie [Royaume-Uni] ; Nigel Williams [Royaume-Uni] ; Melissa Hack [Royaume-Uni] ; Jason D. Warren [Royaume-Uni] ; Huw R. Morris [Royaume-Uni]	Perry syndrome due to the DCTN1 G71R mutation: A distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure
001B56 (2010)	Szu-Chia Lai ; Shih-Ming Jung [Taïwan] ; Padraic Grattan-Smith [Australie] ; Ella Sugo [Australie] ; Yen-Wen Lin [Taïwan] ; Rou-Shayn Chen ; Chiung-Chu Chen ; Yah-Huei Wu-Chou [Taïwan] ; Anthony E. Lang [Canada] ; Chin-Song Lu	Neuronal intranuclear inclusion disease: Two cases of dopa‐responsive juvenile parkinsonism with drug‐induced dyskinesia
001B80 (2010)	Bobby Thomas [États-Unis] ; M. Flint Beal [États-Unis]	Mitochondrial therapies for Parkinson's disease
001D23 (2010)	Coro Paisán-Ruiz [Royaume-Uni] ; Rocio Guevara [Royaume-Uni] ; Monica Federoff [Royaume-Uni] ; Hasmet Hanagasi [Turquie] ; Fardaz Sina [Iran] ; Elahe Elahi [Iran] ; Susanne A. Schneider [Royaume-Uni, Allemagne] ; Petra Schwingenschuh [Allemagne] ; Nin Bajaj [Royaume-Uni] ; Murat Emre [Turquie] ; Andrew B. Singleton [États-Unis] ; John Hardy [Royaume-Uni] ; Kailash P. Bhatia [Allemagne] ; Sebastian Brandner [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Henry Houlden [Royaume-Uni]	Early‐onset L‐dopa‐responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations
001D30 (2010)	Amitabh Gupta [Canada] ; Anthony E. Lang [Canada]	Drug‐induced cranial myoclonus

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinsonian Disorders (drug therapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinsonian Disorders (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinsonian Disorders (drug therapy)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024